Sinoviortesis con radioisótopos en hemofilia: Experiencia de un centro en Chile / Radionuclide synoviorthesis in hemophilia: experience in 107 patients
Rev. méd. Chile
;
147(5): 568-573, mayo 2019. tab, graf
Article
in Spanish
| LILACS
| ID: biblio-1014265
ABSTRACT
Background:
In patients with hemophilia, radionuclide synoviorthesis, or the intra-articular injection of a radionuclide to decrease the synovial hypertrophy tissue, aims to decrease or avoid hemarthrosis.Aim:
To evaluate the effectiveness of radionuclide synoviorthesis in hemophilia. Material andMethods:
Observational retrospective study of the evolution of 107 male patients aged 3 to 54 years who were subjected to radionuclide synoviorthesis between 2007 and 2015.Results:
Of 164 treated joints, in 65% treatment was successful, (defined as zero to two hemarthroses and absence of synovitis during the follow up period), in 17% it was partially successful (defined as two or less hemarthroses, but persistence of the synovitis) and failed in 18% of the procedures. No important complications were recorded.Conclusions:
Radionuclide synoviorthesis has an overall 82% success rate, is minimally invasive, can be used at any age and is inexpensive We recommend its implementation in Chilean hemophilia treatment centers.
Full text:
Available
Index:
LILACS (Americas)
Main subject:
Radioisotopes
/
Rhenium
/
Synovitis
/
Yttrium Radioisotopes
/
Hemarthrosis
/
Hemophilia A
Type of study:
Observational study
Limits:
Adolescent
/
Adult
/
Child
/
Child, preschool
/
Humans
/
Male
Country/Region as subject:
South America
/
Chile
Language:
Spanish
Journal:
Rev. méd. Chile
Journal subject:
Medicine
Year:
2019
Type:
Article
Affiliation country:
Chile
Institution/Affiliation country:
Hospital San José/CL
/
Hospital de niños Roberto del Río/CL
/
Universidad de Chile/CL
Similar
MEDLINE
...
LILACS
LIS